Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously disclosed by Aspen Aerogels, Inc. (the "Company") in its
definitive proxy statements on Schedule 14A, on December 10, 2015 (the "Grant
Date"), the Company granted Donald R. Young, the Chief Executive Officer of the
Company, a non-qualified stock option to purchase 370,181 shares of common
stock, of which 116,279 of the shares (the "SEIG Performance Option") will vest
and become exercisable on the fifth anniversary of the Grant Date provided that
the 30 day volume weighted average price of the Company's common stock on the
New York Stock Exchange (the "VWAP") shall be at least $8.96 for at least 60
consecutive trading days during such five-year period (the "Performance
Period"). On December 10, 2020, the board of directors of the Company approved
an amendment to the SEIG Performance Option to extend the Performance Period
during which Mr. Young may achieve the price targets on the vesting of such
option such that the Performance Period ends on December 18, 2020.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses